Home breathing device study for stable chronic respiratory failure
Part of Lungs & breathing clinical trials.
This trial compares two types of breathing support you can use at home—high-flow nasal cannula (a gentle flow of warm, moist air through the nose) and noninvasive ventilation (a mask that helps push air into your lungs). The goal is to see which one works better for people with stable COPD and high carbon dioxide levels in their blood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years or older.
- You have been diagnosed with COPD (chronic obstructive pulmonary disease).
- Your carbon dioxide level in the blood is above 45 mmHg when you are stable (not having a flare-up).
- You can read and write in Korean.
- You have not had a bad breathing flare-up in the last four weeks.
- You do not have trouble wearing a mask or the nasal device.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how different breathing support strategies affect people with COPD who have high carbon dioxide (CO2) in their blood. It may help care teams choose safer respiratory support after a breathing machine is stopped.
This trial tests whether using a non-invasive ventilator (a breathing machine with a mask) at home can help people with severe COPD who have high carbon dioxide levels in their blood. It aims to improve breathing and reduce the need for hospital visits.
This study tests whether a special nasal breathing device (nasal high flow) can help people with COPD exercise longer and more comfortably. It compares the device to standard low-flow oxygen or no oxygen at all.
This study compares two breathing support options for people hospitalized with a COPD flare-up and high carbon dioxide levels in the blood. It aims to see which option works better and is safer for breathing and recovery.
This trial tests whether home telemonitoring combined with a breathing machine (non-invasive ventilation) can help people with advanced COPD and persistently high carbon dioxide levels. It aims to improve care and reduce hospital visits.
This study looks at whether nighttime breathing problems can predict long-term success with a non-invasive breathing machine in people with COPD who have high carbon dioxide levels in their blood. The goal is to help doctors decide who will benefit most from this therapy.
Hear when a new Stable Chronic Hypercapnic Respiratory Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.